South Africa Embolotherapy Market
The South Africa Embolotherapy Market size was valued at US$ 42.09 Mn in 2021 and is projected to reach US$ 65.47 Mn by 2028, growing at a CAGR of 6.5% during 2022 - 2028.
Report Coverage
- Product: Embolic Agents, Support Devices
- Disease Indication: Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological & Nephrological Disorders, Gastrointestinal Disorders
- Procedure: Transcatheter Arterial Embolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transarterial Chemoembolization
- End User: Hospitals & Clinics, Ambulatory Surgery Centers, Other End Users
US$ 42.09 Mn
Market size in 2021
US$ 65.47 Mn
Market Size by 2028
6.5%
CAGR, 2022 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South Africa Embolotherapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South Africa Embolotherapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South Africa Embolotherapy Market Regional Analysis
6.2 South Africa Embolotherapy Market Revenue 2019-2028 (US$ Million)
6.3 South Africa Embolotherapy Market Forecast Analysis
7. South Africa Embolotherapy Market Analysis – by Product
7.1 Embolic Agents
- 7.1.1 Overview
- 7.1.2 Embolic Agents: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Support Devices
- 7.2.1 Overview
- 7.2.2 Support Devices: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. South Africa Embolotherapy Market Analysis – by Disease Indication
8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Cancer: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Peripheral Vascular Disease
- 8.2.1 Overview
- 8.2.2 Peripheral Vascular Disease: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Neurological Diseases
- 8.3.1 Overview
- 8.3.2 Neurological Diseases: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Urological & Nephrological Disorders
- 8.4.1 Overview
- 8.4.2 Urological & Nephrological Disorders: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Gastrointestinal Disorders
- 8.5.1 Overview
- 8.5.2 Gastrointestinal Disorders: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. South Africa Embolotherapy Market Analysis – by Procedure
9.1 Transcatheter Arterial Embolization
- 9.1.1 Overview
- 9.1.2 Transcatheter Arterial Embolization: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
- 9.2.1 Overview
- 9.2.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Transarterial Chemoembolization
- 9.3.1 Overview
- 9.3.2 Transarterial Chemoembolization: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. South Africa Embolotherapy Market Analysis – by End User
10.1 Hospitals & Clinics
- 10.1.1 Overview
- 10.1.2 Hospitals & Clinics: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Ambulatory Surgery Centers
- 10.2.1 Overview
- 10.2.2 Ambulatory Surgery Centers: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Other End Users
- 10.3.1 Overview
- 10.3.2 Other End Users : South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. South Africa Embolotherapy Market – South Africa Analysis
11.1 Overview
11.2 South Africa- 11.2.1 South Africa Embolotherapy Market Breakdown, by Key Country, 2022 and 2028 (%)
- 11.2.1.1 South Africa Embolotherapy Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 South Africa: South Africa Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 South Africa: South Africa Embolotherapy Market Breakdown, by Product
- 11.2.1.1.2 South Africa: South Africa Embolotherapy Market Breakdown, by Disease Indication
- 11.2.1.1.3 South Africa: South Africa Embolotherapy Market Breakdown, by Procedure
- 11.2.1.1.4 South Africa: South Africa Embolotherapy Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Boston Scientific Corporation
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Cook Medical LLC
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Johnson & Johnson Consumer Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Medtronic
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Acandis GmbH
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Terumo Corporation
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Balt USA LLC
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Stryker Corporation
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Guerbet LLC.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full S Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
